Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial

European Urology

Volumn 72, Issue 2, 2017, Pages 293-299

  Taaffe, Dennis R ^a,b   Newton, Robert U ^a,c,d   Spry, Nigel ^a,e,f   Joseph, David ^a,f,g   Chambers, Suzanne K ^a,h,i,j   Gardiner, Robert A ^a,d,k   Wall, Brad A ^a,l   Cormie, Prue ^m   Bolam, Kate A ^b,n   Galvão, Daniel A ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e Genesis Cancer Care   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^h GRIFFITH UNIVERSITY   (Australia)

ⁱ CANCER COUNCIL QUEENSLAND   (Australia)

^j PROSTATE CANCER FOUNDATION OF AUSTRALIA   (Australia)

^k ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^l MURDOCH UNIVERSITY   (Australia)

^m AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

ⁿ SWEDISH SCHOOL OF SPORT AND HEALTH SCIENCES   (Sweden)

more..

Author keywords

Aerobic exercise; Androgen deprivation therapy; Exercise; Exercise prescription; Fatigue; Prostate cancer; Resistance exercise

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ADVERSE OUTCOME; AEROBIC EXERCISE; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; AUSTRALIA; AUSTRALIAN; BACKACHE; BIOMECHANICS; BIOPHYSICS; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER HORMONE THERAPY; CANCER PATIENT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL EVALUATION; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYCLING; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; FOLLOW UP; FUNCTIONAL STATUS; HOME CARE; HUMAN; IMPACT LOADING; INTERVENTION STUDY; KINESIOTHERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MECHANICS; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SHORT FORM 36; SHOULDER DISEASE; SPINAL CORD COMPRESSION; TREATMENT WITHDRAWAL; VITALITY; WALKING DIFFICULTY; CLINICAL TRIAL; COMPARATIVE STUDY; EXERCISE TOLERANCE; FATIGUE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PROCEDURES; PROSTATE TUMOR; PUBLICATION; QUEENSLAND; QUESTIONNAIRE; TIME FACTOR; TREATMENT OUTCOME; WESTERN AUSTRALIA;

AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BICYCLING; EXERCISE THERAPY; EXERCISE TOLERANCE; FATIGUE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PROSTATIC NEOPLASMS; QUEENSLAND; RESISTANCE TRAINING; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 85013817168     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2017.02.019     Document Type: Article

References (29)

1. Nguyen, P.L., Alibhai, S.M., Basaria, S., et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67 (2014), 825–835.
2. Storey, D.J., McLaren, D.B., Atkinson, M.A., et al. Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapy. Ann Oncol 23 (2012), 1542–1549.
3. Schmitz, K.H., Courneya, K.S., Matthews, C., et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42 (2010), 1409–1426.
4. Bourke, L., Smith, D., Steed, L., et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol 69 (2016), 693–703.
5. Galvao, D.A., Taaffe, D.R., Spry, N., Joseph, D., Newton, R.U., Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28 (2010), 340–347.
6. Cormie, P., Galvao, D.A., Spry, N., et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int 115 (2015), 256–266.
7. Segal, R.J., Reid, R.D., Courneya, K.S., et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21 (2003), 1653–1659.
8. Segal, R.J., Reid, R.D., Courneya, K.S., et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27 (2009), 344–351.
9. Bourke, L., Gilbert, S., Hooper, R., et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 65 (2014), 865–872.
10. Bourke, L., Doll, H., Crank, H., Daley, A., Rosario, D., Saxton, J.M., Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 20 (2011), 647–657.
11. Newton, R.U., Taaffe, D.R., Spry, N., et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer, 9, 2009, 210.
12. Galvao, D.A., Spry, N., Denham, J., et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 65 (2014), 856–864.
13. Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365–376.
14. Ware, J.E. Jr., Sherbourne, C.D., The, M.O.S., 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992), 473–483.
15. Ware, J.E. Jr., Kosinski, M., Bjorner, J.B., Turner-Bowker, D.M., Gandek, B., Maruish, M.E., User's Manual for the SF-36v2 Health Survey. ed. 2, 2008, QualityMetric Incorporated, Rhode Island.
16. Newman, A.B., Simonsick, E.M., Naydeck, B.L., et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 295 (2006), 2018–2026.
17. Taaffe, D.R., Duret, C., Wheeler, S., Marcus, R., Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults. J Am Geriatr Soc 47 (1999), 1208–1214.
18. Vellas, B., Guigoz, Y., Garry, P.J., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15 (1999), 116–122.
19. Godin, G., Shephard, R.J., A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 10 (1985), 141–146.
20. Nordin, A., Taft, C., Lundgren-Nilsson, A., Dencker, A., Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med Res Methodol, 16, 2016, 62.
21. Thabane, L., Mbuagbaw, L., Zhang, S., et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol, 13, 2013, 92.
22. Gavin, A.T., Drummond, F.J., Donnelly, C., O'Leary, E., Sharp, L., Kinnear, H.R., Patient-reported “ever had” and “current” long-term physical symptoms after prostate cancer treatments. BJU Int 116 (2015), 397–406.
23. Scott, N.W., Fayers, P.M., Aaronson, N.K., et al. EORTC QLQ-C30 reference values. 2008, EORTC Quality of Life Group, Brussels, Belgium.
24. Potosky, A.L., Reeve, B.B., Clegg, L.X., et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94 (2002), 430–437.
25. Alibhai, S.M., Breunis, H., Timilshina, N., et al. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol 28 (2010), 5038–5045.
26. Bjorner, J.B., Wallenstein, G.V., Martin, M.C., et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 23 (2007), 731–739.
27. Galvão, D.A., Newton, R.U., Gardiner, R.A., et al. Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life. Psycho-Oncology 24 (2015), 1241–1249.
28. Simonsick, E.M., Fan, E., Fleg, J.L., Estimating cardiorespiratory fitness in well-functioning older adults: treadmill validation of the long distance corridor walk. J Am Geriatr Soc 54 (2006), 127–132.
29. Minton, O., Stone, P., A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20 (2009), 17–25.